DNA Vectors
IBA LifeSciences StrGate Acptr Vctr pESG-IBAwt2
The pESG-IBAwt2 vector is designed for high-level, stable, and non-replicative transient expression of target proteins without affinity tag in mammalian cells. The vector carries an ampicillin resistance cassette for selection of transformed E. coli cells as well as the F1 and ColE1 origin for a high plasmid copy number. In addition, it carries the human cytomegalovirus (CMV) immediate-early promoter for high-level expression, and the SV40 ori for episomal replication in cell lines that are latently infected with SV40 or that express the SV40 large T antigen (e.g. HEK293T, COS-1, COS-7). BM40 secretory signal peptide is encoded for the transfer of the expressed protein into the medium. During translocation from the cytosol the signal peptide is removed from the protein by endogenous proteases. In addition to the direct cloning of the gene of interest into pESG-IBA vectors with Esp3I, another option via a so-called Entry Vector is possible.
U.S. Pharmacopeia AAV8 for Capsid Titer (100 uL) (COLD SHIPMENT REQUIRED)
AAV8 for Capsid Titer (100 uL) (COLD SHIPMENT REQUIRED)
System Biosciences LLC PCDH-CMV-MCS-EF1A-PURO CDNA DU
pCDH-CMV-MCS-EF1α-Puro cDNA Dual Promoter Cloning and Expression Lentivector
IBA LifeSciences StrGate Acptr Vctr pCSG-IBA103
pCSG-IBA103 is a large expression vector with universal features for transient expression of target proteins with a C-terminal Twin-Strep-tag as well as for generation of stable mammalian cell lines. The vector carries an ampicillin resistance cassette for selection of transformed E. coli cells and ColE1 origin for a high plasmid copy number. Extrachromosomal replication in mammalian cells could occur either by origin of replication from Epstein-Barr Virus (oriP) or by SV40 ori. For the former the vector provides the EBNA-1 gene and for the latter the cell line has to be latently infected with SV40 or express the SV40 large T antigen (e.g. HEK293T, COS-1, COS-7). Stable cell lines can be selected by the neomycin resistance gene (NeoR). In addition, the human cytomegalovirus (CMV) immediate-early promoter enables a high-level expression in a wide range of mammalian cells.
IBA LifeSciences StrGate Acptr Vctr pESG-IBA104
The pESG-IBA104 vector is designed for high-level, stable, and non-replicative transient expression of target proteins with an N-terminal Twin-Strep-tag in mammalian cells. The vector carries an ampicillin resistance cassette for selection of transformed E. coli cells as well as the F1 and ColE1 origin for a high plasmid copy number. In addition, it carries the human cytomegalovirus (CMV) immediate-early promoter for high-level expression, the neomycin resistance gene for selection of stable cell lines, and the SV40 ori for episomal replication in cell lines that are latently infected with SV40 or that express the SV40 large T antigen (e.g. HEK293T, COS-1, COS-7). BM40 secretory signal peptide is encoded for the transfer of the expressed protein into the medium. During translocation from the cytosol the signal peptide is removed from the protein. In addition to the direct cloning of the gene of interest into pESG-IBA vectors with Esp3I, another option via Entry Vector is possible.
IBA LifeSciences StrGate Acptr Vctr pASG-IBA145
The pASG-IBA145 vector is designed for expression of recombinant proteins with an N-terminal Twin-Strep-tag and C-terminal His-tag in E. coli. The vector carries an ampicillin resistance cassette for selection of transformed E. coli cells, F1 and ColE1 origin for a high plasmid copy number, and the inducible tetracycline promoter/operator for the regulated expression of proteins. Expression of the recombinant protein is induced by addition of anhydrotetracycline, which is a derivative of tetracycline that does not exhibit antibiotic activity. In addition to the direct cloning of the gene of interest into pASG-IBA vectors with Esp3I, another option via a so-called Entry Vector is possible.
IBA LifeSciences StrGate Acptr Vctr pASG-IBA5
The pASG-IBA5 vector is designed for expression of recombinant proteins with an N-terminal Strep-tagII in E. coli. The vector carries an ampicillin resistance cassette for selection of transformed E. coli cells, F1 and ColE1 origin for a high plasmid copy number, and the inducible tetracycline promoter/operator for the regulated expression of proteins. The vector can be combined with any E. coli strain since the tet-promoter works independently of the genetic background of E. coli. Expression of the recombinant protein is induced by addition of anhydrotetracycline, which is a derivative of tetracycline that does not exhibit antibiotic activity. Please note that cloning into pASG-IBA Acceptor Vectors compulsorily requires the restriction enzyme Esp3I since no other MCS for the integration of a gene of interest is available. In addition to the direct cloning of the gene of interest into pASG-IBA vectors with Esp3I, another option via a so-called Entry Vector is possible.
HORIZON DISCOVERY BIOSCIENCES LIMITED HUMAN KRAS G12V/ LIM1215 CE
NC2198029 HUMAN KRAS G12V/ LIM1215 CE